非酒精性脂肪性肝炎市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00009653
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 178
Buy Now

非酒精性脂肪性肝炎 (NASH) 市场预计将从 2021 年的 16.3192 亿美元增至 2028 年的 242.6681 亿美元;预计 2021 年至 2028 年复合年增长率为 47.1%。

在非酒精性脂肪肝疾病 (NAFLD) 中,脂肪会在肝脏中积聚。非酒精性脂肪肝 (NAFL) 和非酒精性脂肪性肝炎 (NASH) 是 NAFLD 的类型。当脂肪堆积引起炎症和损伤时,就会导致 NASH 的发展,从而导致肝脏疤痕。肝脏疤痕是一种可能危及生命的疾病,称为肝硬化。

该报告提供了对非酒精性脂肪性肝炎 (NASH) 市场的见解和深入分析,强调了市场趋势、技术进步和市场动态等各种参数。它还提供全球领先市场参与者的竞争格局分析。此外,它还包括 COVID-19 大流行对所有地区市场的影响。 COVID-19 大流行扰乱了世界各国的社会经济状况。在北美,美国受到了 COVID-19 大流行的深刻影响。 COVID-19 患者中转氨酶升高和高胆红素血症形式的肝损伤可归因于多种因素,包括先前存在的肝病。这些患者同时患有非酒精性脂肪性肝病 (NAFLD) 和 NASH,使他们容易出现严重的肝损伤。鉴于 NAFLD 在全球范围内的高患病率,认识到此类患者中 COVID-19 的结果至关重要,其中包括合并症、疾病进展和 COVID 严重程度的作用。在 COVID-19 患者中,纤维化而非 NASH/NAFLD 的存在与较差的临床结果和较高的死亡率相关。

COVID-19 对共病患者群体的影响包括糖尿病、肥胖症、脂肪肝病和 NASH 患者,引发了为患者提供最佳护理的需求。全球肝脏研究所致力于与世界各地的研究人员和创新者合作,快速评估并通报针对这一流行病的强有力的应对措施。围绕对抗 NAFLD 和 NASH 的研究表明,预期与体重问题的关系是显而易见的。因此,NASH 的高发病率需要先进的诊断和治疗,这促进了市场的研究和开发。因此,COVID-19 危机推动了非酒精性脂肪性肝炎 (NASH) 市场的增长。

  

战略见解

非酒精性脂肪性肝炎 (NASH) 市场利润丰厚的地区

市场洞察

增加 NASH 意识的举措推动市场增长

NASH 是一种未被充分认识的疾病。为了建立结构化的转诊途径和早期发现,提高公众和初级保健医生 (PCP) 对这种疾病的认识至关重要。通过建立明确的患者转诊途径和患者意识活动,可以识别更多的患者并将其发送给专家进行进一步评估。为了提高对 NASH 的认识,NASH 教育计划于 2018 年 6 月 12 日(即“国际 NASH 日”)发起了公众教育活动,以提高对 NAFLD 及其更高级形式 NASH 的认识,NASH 影响了约 1.15 亿人

NASH 24X7 是一个数字平台,旨在提高对 NASH 流行病的曝光和认识,通过 HCP 支持、患者意识,在 2019 年国际 NASH 日采取了一些措施,以及新闻/电视发布节目。为了提高人们对这一天的认识,NASH 24X7 的 NASH Crusaders 与印度各地的顶级医疗保健提供者 (HCP),特别是胃肠病学家和肝病学家合作,举办了许多小规模和大规模的认识和宣传活动。关于肝脏健康的教育研讨会,强调健康的生活方式对于预防 NAFLD/NASH 的必要性。

在 2020 年国际 NASH 日,美国肝脏基金会与全球社区一起,在艾尔建基金会的支持下提高人们对 NASH 的认识。美国肝脏基金会 (ALF) 目前正在试行 NASH 短信计划,人们可以注册以在 10 周内每周接收 3 条消息。消息包括 NASH 资源的超链接、相关事实、互动测验以及日常自我管理的明智指南。当试点完成并评估后,ALF 将向公众开放该系统。它在国际 NASH 日与全球肝脏研究所 (GLI) 合作,并分享了一些与 GLI 帖子和国际 NASH 日页面链接的社交媒体帖子。

因此,不断提高的 NASH 意识举措正在推动非酒精性脂肪性肝炎 (NASH) 市场的发展。

基于产品的见解

基于在产品上,非酒精性脂肪性肝炎 (NASH) 市场细分为维生素 E 和吡格列酮、ocaliva、elafibranor、selonsertib 和塞尼基韦罗等。 2021年,其他细分市场占据最大市场份额。 selonsertib 和cenicriviroc 细分市场预计在预测期内复合年增长率最快,达到 73.3%。

器官保存解决方案市场(按产品) 2020 年和 2028 年

基于应用的见解

根据应用,非酒精性脂肪性肝炎 (NASH) 市场分为治疗和诊断。 2021年,治疗领域占据了更大的市场份额。然而,预计治疗领域在预测期内的复合年增长率将达到 47.3%。

基于销售渠道的洞察

基于从销售渠道来看,非酒精性脂肪性肝炎(NASH)市场分为医院药房、零售药房和在线提供商。 2021年,零售药房领域占据最大的市场份额。此外,零售药房领域预计 2021 年至 2028 年的复合年增长率将达到 47.2%。

非酒精性脂肪性肝炎 (NASH) 市场参与者采取有机策略例如产品发布和扩张,以扩大其在全球的足迹和产品组合,以及满足不断增长的需求。

按地理位置

基于从地理位置来看,非酒精性脂肪性肝炎 (NASH) 市场分为北美(美国、加拿大和墨西哥)、欧洲(英国、德国、法国、意大利、西班牙和欧洲其他地区)、亚太地区(中国、日本) 、印度、澳大利亚、韩国和亚太地区其他地区)、中东和美国非洲(阿联酋、沙特阿拉伯、南非以及中东和非洲其他地区)以及南美和非洲中美洲(巴西、阿根廷以及南美洲和中美洲其他地区)。

公司简介

  • Genfit SA
  • One Way Liver, SL
  • BioPredictive SAS
  • 卡迪拉制药有限公司
  • 普罗米修斯实验室
  • 西门子 Healthineers AG
  • Intercept Pharmaceuticals, Inc.
  • 诺华公司
  • Galmed Pharmaceuticals
  • 美国实验室控股公司           
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is non-alcoholic steatohepatitis (NASH)?

Nonalcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in your liver. Nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH) are types of NAFLD. Non-alcoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty liver disease (NAFLD). NAFLD is caused by buildup of fat in the liver. When this buildup causes inflammation and damage, it is known as NASH, which can lead to scarring of the liver. Scarring of the liver is a potentially life-threatening condition called cirrhosis.

What are the driving factors for the non-alcoholic steatohepatitis (NASH) market across the globe?

Key factors that are driving the growth of this market are the rising prevalence of NASH and increasing initiatives for the awareness of NASH. Additionally, the growing clinical trials involving combination studies of drugs is likely to emerge as a significant future trend in the market during the forecast period.

What is the market CAGR value of the non-alcoholic steatohepatitis (NASH) market during the forecast period?

The CAGR value of the non-alcoholic steatohepatitis (NASH) market during the forecasted period of 2021–2028 is 47.1%.

Which product led the non-alcoholic steatohepatitis (NASH) market?

The product segment of the non-alcoholic steatohepatitis (NASH) market is segmented into vitamin E and pioglitazone, ocaliva, elafibranor, selonsertib & cenicriviroc, and others. In 2021, the others segment held the largest share of the market, by product. The selonsertib & cenicriviroc segment of the non-alcoholic steatohepatitis (NASH) market is expected to witness growth in its demand at the fastest CAGR of 73.3% from 2024 to 2028.

Which application held the largest share in the non-alcoholic steatohepatitis (NASH) market?

The treatment segment dominated the global non-alcoholic steatohepatitis (NASH) market and accounted for the largest market share of 84.90% in 2021.

Which sales channel held the largest share in the non-alcoholic steatohepatitis (NASH) market?

The retail pharmacy segment dominated the global non-alcoholic steatohepatitis (NASH) market and accounted for the largest market share of 61.39% in 2021.

Who are the key players in the non-alcoholic steatohepatitis (NASH) market?

The non-alcoholic steatohepatitis (NASH) market majorly consists of players such as Genfit SA; One Way Liver, S.L.; BioPredictive S.A.S.; Cadila Pharmaceuticals Ltd.; Prometheus Laboratories; Siemens Healthineers AG; Intercept Pharmaceuticals, Inc.; Novartis AG; Galmed Pharmaceuticals; and Laboratory Corporation of America Holdings amongst others.

Which are the top companies that hold the market share in non-alcoholic steatohepatitis (NASH) market?

Intercept Pharmaceuticals, Inc and Genfit SA are the top two companies that hold huge market shares in the non-alcoholic steatohepatitis (NASH) market.

Which region is expected to witness significant demand for the non-alcoholic steatohepatitis (NASH) market in the coming years?

North America held the largest market share for non-alcoholic steatohepatitis in 2021. The United States held the largest market in North America for non-alcoholic steatohepatitis, and the market is expected to grow due to increasing adoption of technological advancements and rising emphasis on improving treatment outcomes are projected to accelerate the growth of the non-alcoholic steatohepatitis market.

What is the COVID 19 impact on the non-alcoholic steatohepatitis (NASH) market in the coming years?

The presence of nonalcoholic fatty liver disease (NAFLD) and NASH in patients with COVID-19 is likely to cause them to be prone to severe forms of liver injury. Given the high prevalence of NAFLD worldwide, it's far critical to recognize the results of COVID-19 in such patients, which include the role of comorbidities, disease progression, and the severity of COVID-19. The presence of fibrosis rather than NASH/NAFLD is associated with worse clinical outcomes and higher mortality in COVID-19 patients. Additionally, there seems to be an increased likelihood of liver injury in NAFLD patients with COVID-19.
NASH had the strongest association with COVID-19 of all comorbid metabolic conditions, including hypertension and obesity. As the world keeps confronting the novel coronavirus pandemic, the impact of COVID-19 on specific patient populations, which includes people with diabetes, obesity, fatty liver disease, and NASH, has proven the need of providing actionable recommendations to clinicians and patients to offer optimal care and avoid needless deaths. The Global Liver Institute is committed to operating with researchers and innovators worldwide to evaluate and inform a strong response to this pandemic rapidly. As the push to combat NAFLD and NASH continues, research indicates that the anticipated relationship with weight problems is stark. Individuals with signs and symptoms of underlying fatty liver disease and NASH are at higher risk and infectious for longer for COVID-19. Therefore, COVID-19 is affected positively on the growth of the market.

The List of Companies - Non-Alcoholic Steatohepatitis (NASH) Market
  1. Genfit SA
  2. One Way Liver, S.L.
  3. BioPredictive S.A.S
  4. Cadila Pharmaceuticals Ltd.
  5. Prometheus Laboratories
  6. Siemens Healthineers AG
  7. Intercept Pharmaceuticals, Inc.
  8. Novartis AG
  9. Galmed Pharmaceuticals
  10. Laboratory Corporation of America Holdings

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports